Concomitant Treatment of Chronic Hepatitis C With Direct-Acting Antivirals and Multidrug-Resistant Tuberculosis Is Effective and Safe

We assessed effectiveness and safety of concomitant chronic hepatitis C virus (HCV) treatment with direct-acting antivirals (DAAs) and multidrug-resistant tuberculosis (MDR-TB). Of 322 MDR-TB patients (19.4% HCV), 30 were treated concomitantly (23.3% human immunodeficiency virus-positive). Overall,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Melikyan, Nara, Huerga, Helena, Atshemyan, Hakob, Kirakosyan, Ohanna, Sargsyants, Narina, Aydinyan, Tsovinar, Saribekyan, Nora, Khachatryan, Naira, Oganezova, Izabella, Falcao, Joana, Balkan, Suna, Hewison, Cathy
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7896641/
https://ncbi.nlm.nih.gov/pubmed/33634203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa653
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares